Cite
HARVARD Citation
Hoffmann, L. et al. (2022). Thorough design and pre-trial quality assurance (QA) decrease dosimetric impact of delineation and dose planning variability in the STRICTLUNG and STARLUNG trials for stereotactic body radiotherapy (SBRT) of central and ultra-central lung tumours. Radiotherapy and oncology. pp. 53-61. [Online].